GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 127 filers reported holding GOSSAMER BIO INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,588,841 | -58.9% | 309,300 | -57.3% | 0.00% | 0.0% |
| Q1 2022 | $6,291,264 | -23.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $8,197,000 | -10.0% | 724,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,111,000 | +54.8% | 724,800 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $5,885,000 | -12.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $6,704,000 | -23.5% | 724,800 | -20.0% | 0.00% | 0.0% |
| Q4 2020 | $8,761,000 | -22.1% | 906,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $11,243,000 | -4.5% | 906,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,778,000 | +146.9% | 906,000 | +92.8% | 0.00% | +50.0% |
| Q1 2020 | $4,771,000 | -61.6% | 470,000 | -40.8% | 0.00% | -33.3% |
| Q4 2019 | $12,415,000 | -0.5% | 794,275 | +6.9% | 0.00% | -25.0% |
| Q3 2019 | $12,475,000 | -14.4% | 742,991 | +13.1% | 0.00% | -20.0% |
| Q2 2019 | $14,574,000 | +43.1% | 657,081 | +39.8% | 0.01% | +66.7% |
| Q1 2019 | $10,185,000 | – | 470,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,275,726 | $43,399,000 | 17.96% |
| Boxer Capital, LLC | 2,185,000 | $22,178,000 | 1.51% |
| HHLR ADVISORS, LTD. | 5,911,541 | $60,002,000 | 0.81% |
| Artal Group S.A. | 1,808,968 | $18,361,000 | 0.78% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $4,667,000 | 0.46% |
| Spark Investment Management LLC | 39,906 | $405,000 | 0.22% |
| Alyeska Investment Group, L.P. | 476,838 | $4,840,000 | 0.10% |
| Cormorant Asset Management, LP | 198,382 | $2,014,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 36,101 | $366,000 | 0.09% |
| Redmile Group, LLC | 259,700 | $2,636,000 | 0.07% |